HEPATOSPLENIC SCHISTOSOMIASIS-ASSOCIATED CHRONIC PORTAL VEIN THROMBOSIS: RISK FACTOR FOR HEPATOCELLULAR CARCINOMA?

ABSTRACT BACKGROUND: Hepatosplenic schistosomiasis is an endemic disease prevalent in tropical countries and is associated with a high incidence of portal vein thrombosis. Inflammatory changes caused by both parasitic infection and portal thrombosis can lead to the development of chronic liver dise...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: George Felipe Bezerra Darce, Fabio Ferrari Makdissi, Sabrina de Mello Ando, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Fabricio Ferreira Coelho, Manoel de Souza Rocha, Paulo Herman
Formaat: Artikel
Taal:English
Gepubliceerd in: Colégio Brasileiro de Cirurgia Digestiva 2023-09-01
Reeks:ABCD: Arquivos Brasileiros de Cirurgia Digestiva
Onderwerpen:
Online toegang:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202023000100330&lng=en&tlng=en
Omschrijving
Samenvatting:ABSTRACT BACKGROUND: Hepatosplenic schistosomiasis is an endemic disease prevalent in tropical countries and is associated with a high incidence of portal vein thrombosis. Inflammatory changes caused by both parasitic infection and portal thrombosis can lead to the development of chronic liver disease with potential carcinogenesis. AIMS: To assess the incidence of portal vein thrombosis and hepatocellular carcinoma in patients with schistosomiasis during long-term follow-up. METHODS: A retrospective study was conducted involving patients with schistosomiasis followed up at our institution between 1990 and 2021. RESULTS: A total of 126 patients with schistosomiasis were evaluated in the study. The mean follow-up time was 16 years (range 5–31). Of the total, 73 (57.9%) patients presented portal vein thrombosis during follow-up. Six (8.1%) of them were diagnosed with hepatocellular carcinoma, all with portal vein thrombosis diagnosed more than ten years before. CONCLUSIONS: The incidence of hepatocellular carcinoma in patients with schistosomiasis and chronic portal vein thrombosis highlights the importance of a systematic long-term follow-up in this group of patients.
ISSN:0102-6720